{"id":"https://openalex.org/W1964287543","doi":"https://doi.org/10.1016/j.juro.2010.03.147","title":"A Multicenter, Double-Blind, Randomized, Placebo Controlled Trial of a Neurokinin-1 Receptor Antagonist for Overactive Bladder","display_name":"A Multicenter, Double-Blind, Randomized, Placebo Controlled Trial of a Neurokinin-1 Receptor Antagonist for Overactive Bladder","alternate_titles":[],"publication_year":2010,"publication_date":"2010-06-21","ids":{"openalex":"https://openalex.org/W1964287543","doi":"https://doi.org/10.1016/j.juro.2010.03.147","mag":"1964287543","pmid":"https://pubmed.ncbi.nlm.nih.gov/20639026"},"language":"en","primary_location":{"id":"doi:10.1016/j.juro.2010.03.147","doi":"https://doi.org/10.1016/j.juro.2010.03.147","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.juro.2010.03.147","pdf_url":null,"source":{"id":"https://openalex.org/S30525748","display_name":"The Journal of Urology","issn_l":"0022-5347","issn":["0022-5347","1527-3792"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Urology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1964287543"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004167433","display_name":"Tara Lee Frenkl","orcid":"https://orcid.org/0000-0003-0431-4608","observed_orcids":["https://orcid.org/0000-0003-0431-4608"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tara L. Frenkl","raw_affiliation_strings":["Merck & Co, Inc., Whitehouse Station, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co, Inc., Whitehouse Station, New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110216495","display_name":"Haiyuan Zhu","orcid":"https://orcid.org/0009-0007-0903-9349","observed_orcids":["https://orcid.org/0009-0007-0903-9349"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Haiyuan Zhu","raw_affiliation_strings":["Merck & Co, Inc., Whitehouse Station, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co, Inc., Whitehouse Station, New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108374076","display_name":"Theodore F. Reiss","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Theodore Reiss","raw_affiliation_strings":["Merck & Co, Inc., Whitehouse Station, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co, Inc., Whitehouse Station, New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062029153","display_name":"Olga Seltzer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Olga Seltzer","raw_affiliation_strings":["Merck & Co, Inc., Whitehouse Station, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co, Inc., Whitehouse Station, New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113462524","display_name":"Elizabeth Rosenberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Elizabeth Rosenberg","raw_affiliation_strings":["Merck & Co, Inc., Whitehouse Station, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co, Inc., Whitehouse Station, New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101703063","display_name":"Stuart Green","orcid":"https://orcid.org/0000-0001-5170-7135","observed_orcids":["https://orcid.org/0000-0001-5170-7135"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stuart Green","raw_affiliation_strings":["Merck & Co, Inc., Whitehouse Station, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co, Inc., Whitehouse Station, New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1285764155"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":5.2731,"has_fulltext":false,"cited_by_count":65,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.95397588,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"184","issue":"2","first_page":"616","last_page":"622"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10418","display_name":"Pelvic floor disorders treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/overactive-bladder","display_name":"overactive bladder","score":0.9459999799728394},{"id":"https://openalex.org/keywords/nk1-receptor-antagonists","display_name":"NK1 receptor antagonists","score":0.9229999780654907},{"id":"https://openalex.org/keywords/tolterodine","display_name":"tolterodine","score":0.9700000286102295},{"id":"https://openalex.org/keywords/urinary-frequency","display_name":"urinary frequency","score":0.7329999804496765},{"id":"https://openalex.org/keywords/urgency","display_name":"urgency","score":0.5789999961853027},{"id":"https://openalex.org/keywords/urge-urinary-incontinence","display_name":"urge urinary incontinence","score":0.9330000281333923},{"id":"https://openalex.org/keywords/xerostomia","display_name":"xerostomia","score":0.8980000019073486},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.6759999990463257},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.3370000123977661}],"concepts":[{"id":"https://openalex.org/C2781020410","wikidata":"https://www.wikidata.org/wiki/Q424312","display_name":"Tolterodine","level":4,"score":0.9020693302154541},{"id":"https://openalex.org/C2778941218","wikidata":"https://www.wikidata.org/wiki/Q331231","display_name":"Overactive bladder","level":3,"score":0.8473466038703918},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8338689804077148},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7909607887268066},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.703095555305481},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5598644614219666},{"id":"https://openalex.org/C2778531004","wikidata":"https://www.wikidata.org/wiki/Q281490","display_name":"Urinary incontinence","level":2,"score":0.5278489589691162},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.5048449635505676},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.45452725887298584},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.41143667697906494},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.401614248752594},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3635173738002777},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.30060723423957825},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0622345507144928},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068737","descriptor_name":"Tolterodine Tartrate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001559","descriptor_name":"Benzhydryl Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003408","descriptor_name":"Cresols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010665","descriptor_name":"Phenylpropanolamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018727","descriptor_name":"Muscarinic Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D053201","descriptor_name":"Urinary Bladder, Overactive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D054833","descriptor_name":"Isoindoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D064729","descriptor_name":"Neurokinin-1 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.juro.2010.03.147","doi":"https://doi.org/10.1016/j.juro.2010.03.147","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.juro.2010.03.147","pdf_url":null,"source":{"id":"https://openalex.org/S30525748","display_name":"The Journal of Urology","issn_l":"0022-5347","issn":["0022-5347","1527-3792"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Urology","raw_type":"journal-article"},{"id":"pmid:20639026","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20639026","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of urology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W138509121","https://openalex.org/W1531562711","https://openalex.org/W1585489386","https://openalex.org/W1860985526","https://openalex.org/W1967312126","https://openalex.org/W1978664632","https://openalex.org/W1984754203","https://openalex.org/W1987111921","https://openalex.org/W1987542540","https://openalex.org/W2006171475","https://openalex.org/W2012228261","https://openalex.org/W2018968319","https://openalex.org/W2027396764","https://openalex.org/W2056291238","https://openalex.org/W2067889220","https://openalex.org/W2070500689","https://openalex.org/W2074985715","https://openalex.org/W2082172600","https://openalex.org/W2084336593","https://openalex.org/W2103495340","https://openalex.org/W2119131563","https://openalex.org/W2127743572","https://openalex.org/W2131173377","https://openalex.org/W2134928141","https://openalex.org/W2163252225","https://openalex.org/W2327894593","https://openalex.org/W4402271043"],"related_works":["https://openalex.org/W2082172600","https://openalex.org/W2073468487","https://openalex.org/W1909556211","https://openalex.org/W2377958226","https://openalex.org/W2024975356","https://openalex.org/W2092477693","https://openalex.org/W2026599479","https://openalex.org/W2100949479","https://openalex.org/W2103495340","https://openalex.org/W1982589773"],"abstract_inverted_index":{"PURPOSE:":[0],"Neurokinin-1":[1],"receptor":[2,24,249],"dependent":[3],"mechanisms":[4],"may":[5,251],"regulate":[6],"urinary":[7],"frequency":[8],"and":[9,19,55,117,131,151,156,191,208,221],"urgency.":[10],"We":[11],"conducted":[12],"this":[13,262],"study":[14],"to":[15,72,181,205,271],"assess":[16],"the":[17,22,68,129,226,235,256],"efficacy":[18,134,269],"tolerability":[20],"of":[21,75,119,184,197,230,258],"neurokinin-1":[23],"antagonist":[25],"serlopitant":[26,169,172,185,201],"vs":[27],"placebo":[28,66,162,206],"or":[29,50,57,79,88],"tolterodine":[30,85,158,211],"in":[31,103,142,186,255,268],"patients":[32,69,125],"with":[33,46,240],"overactive":[34,47,259],"bladder.":[35],"MATERIALS":[36],"AND":[37],"METHODS:":[38],"This":[39],"randomized,":[40],"double-blind,":[41],"69-center":[42],"trial":[43,130],"enrolled":[44],"adults":[45],"bladder":[48,260],"(8":[49],"more":[51,58],"average":[52],"daily":[53,59,76,143,231],"micturitions":[54,104,144,188,232],"1":[56,78,167],"urge":[60,114],"incontinence":[61,115],"episodes).":[62],"After":[63],"a":[64,253],"1-week":[65],"run-in":[67],"were":[70],"randomized":[71,126],"8":[73],"weeks":[74],"0.25,":[77],"4":[80,83,152,222],"mg":[81,84,153,168],"serlopitant,":[82,155],"extended":[86],"release":[87],"placebo.":[89,241],"Patients":[90],"kept":[91],"7-day":[92],"voiding":[93],"diaries.":[94],"The":[95,195],"primary":[96,227],"end":[97,108,193,228,237],"point":[98,229],"was":[99,145,175,178,203,214,243],"change":[100,139],"from":[101,140],"baseline":[102,141],"per":[105,189],"day.":[106],"Secondary":[107],"points":[109,238],"included":[110],"urgency,":[111],"total":[112],"incontinence,":[113],"episodes":[116],"incidence":[118,196],"dry":[120,198],"mouth.":[121],"RESULTS:":[122],"Of":[123],"557":[124],"476":[127],"completed":[128],"had":[132],"valid":[133],"data":[135],"for":[136,148,157,161,166],"analysis.":[137],"Mean":[138],"significantly":[146,224],"greater":[147],"0.25":[149],"(-1.1)":[150,154],"(-1.5)":[159],"than":[160,210],"(-0.5),":[163],"but":[164,233,261],"not":[165,234,265],"(-0.8).":[170],"No":[171],"dose":[173],"response":[174],"demonstrated.":[176],"Tolterodine":[177],"numerically":[179],"superior":[180],"all":[182],"doses":[183],"mean":[187],"day":[190],"secondary":[192,236],"points.":[194],"mouth":[199],"on":[200],"(3.3%)":[202],"comparable":[204],"(4.6%)":[207],"lower":[209],"(8.8%).":[212],"Serlopitant":[213,219,242],"generally":[215,244],"well":[216,245],"tolerated.":[217,246],"CONCLUSIONS:":[218],"(0.25":[220],"mg)":[223],"decreased":[225],"compared":[239,270],"Thus,":[247],"NK-1":[248],"antagonists":[250],"have":[252],"role":[254],"treatment":[257],"compound":[263],"does":[264],"offer":[266],"advantages":[267],"tolterodine.":[272]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1964287543","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
